Miruvor
Sign up
The short answer

What studies of strength training found

34papers on strength training
169people in 5 studies testing strength training alone
4randomised trials, the strongest kind of study

At a glance, by condition

Long COVID: C Might help, very uncertain

Based on the strongest evidence, randomised trials and studies with no comparison group (very low certainty): 4 of 6 findings are C.

5 outcomes rated · see each below

ME/CFS: D Little or no difference

Based on the strongest evidence, the randomised trial (very low certainty): 4 findings, all D.

4 outcomes rated · see each below

How we got this

Each condition’s headline comes from its graded findings (one for each outcome and kind of study) rated with the highest certainty: the grade most of them share; a tie goes to the finding with the most people, then the most studies, then the outcome’s name. It sums up the grades below, and conditions are never combined.

What this means: For long COVID, strength training might help some people, but research can’t show it yet. For ME/CFS, studies found little or no difference with strength training. If you’re thinking about it, talk it through with a doctor who knows ME/CFS or long COVID.

Ask about this treatment

Sign up free to read the rest of what studies found.

You’ll see the full picture: how each symptom fared, every grade with its reasons, side effects and all 34 papers.

The grades, in plain words

Each outcome gets a direction, a certainty and a letter read from the two. Certainty is judged with GRADE, the method Cochrane and WHO use.

  1. A
    HelpsImprovement, high certainty
    Probably helpsImprovement, moderate certainty
  2. B
    May helpImprovement, low certainty
  3. Strength training · Long COVID is hereC
    Might help, very uncertainImprovement, very low certainty
    Mixed resultsStudies disagree
  4. Strength training · ME/CFS is hereD
    Little or no differenceStudies found little or no difference
  5. F
    HarmsIt made things worse

By symptom and daily life

Long COVID

Symptoms

Low mood or anxiety2 studies · 115 people took part in strength training Mixed results C
Very low certainty

Why this grade: Mixed results, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; few people (236 in all); only people who finished were analysed; the studies disagree; randomised trials found mixed results.

Randomised trials2 studies · 236 people with results

Studies disagree about low mood or anxiety.

Studies disagree about whether strength training helps low mood or anxiety. Mixed results · very low certainty C

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • Few people (236 in all)
  • Only people who finished were analysed
  • The studies disagree
See the 2 studies
  1. Resistance Exercise Therapy After COVID-19 Infection: A Randomized Clinical Trial. (2025)

    Same trial, also reported in: Resistance Exercise Therapy for Long COVID: a Randomized, Controlled Trial (2025) (Patient Health Questionnaire category)

    People in the study
    233 randomised · 193 analysed
    Dose
    rating of perceived exertion of 8 to 10 (3-5 of 10 in the first week), daily; every 2 weeks telephone or video consultation
    Outcome
    Change in PHQ-4 score category 4-item Patient Health Questionnaire
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    High
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Low
  2. Effectiveness of Functional or Aerobic Exercise Combined With Breathing Techniques in Telerehabilitation for Patients With Long COVID: A Randomized Controlled Trial. (2023)

    People in the study
    54 randomised · 48 started · 43 analysed
    Dose
    8 weeks with a frequency of 3 alternate days/week for about 40 minutes per session
    Outcome
    Perceived stress (Perceived Stress Scale) Perceived Stress Scale
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Low
    Deviations from intended interventions
    High
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Low
Fatigue3 studies · 132 people took part in strength training Little or no difference D
Very low certainty

Why this grade: Little or no difference, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; 236 people in all; a small benefit can't be ruled out; only people who finished were analysed.

Randomised trials2 studies · 236 people with results

No clear difference in fatigue.

The evidence is very uncertain about the effect of strength training on fatigue in long COVID. Little or no difference · very low certainty D

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • 236 people in all; a small benefit can't be ruled out
  • Only people who finished were analysed

Studies with no comparison group17 in the study · 12 weeks · 2 60 min sessions per week on alternate days, with a total of 24 sessions, twice a week, for three months

Fatigue improved.

The evidence is very uncertain about the effect of strength training on fatigue in long COVID. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Few people (17 in all)
See the 3 studies
  1. Effectiveness of Functional or Aerobic Exercise Combined With Breathing Techniques in Telerehabilitation for Patients With Long COVID: A Randomized Controlled Trial. (2023)

    People in the study
    54 randomised · 48 started · 43 analysed
    Dose
    8 weeks with a frequency of 3 alternate days/week for about 40 minutes per session
    Outcome
    Fatigue (Fatigue Assessment Scale) Fatigue Assessment Scale
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Low
    Deviations from intended interventions
    High
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Low
  2. Resistance Exercise Therapy After COVID-19 Infection: A Randomized Clinical Trial. (2025)

    People in the study
    233 randomised · 193 analysed
    Dose
    rating of perceived exertion of 8 to 10 (3-5 of 10 in the first week), daily; every 2 weeks telephone or video consultation
    Outcome
    Fatigue Visual Analogue scale
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    High
    Missing outcome data
    Some concerns
    Measurement of the outcome
    High
    Selection of the reported result
    Low
  3. Improvement of Fatigue and Body Composition in Women with Long COVID After Non-Aerobic Therapeutic Exercise Program. (2025)

    People in the study
    17 in the study
    Dose
    2 60 min sessions per week on alternate days, with a total of 24 sessions, twice a week, for three months
    Outcome
    overall fatigue Modified Fatigue Impact Scale (MFIS)
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Breathlessness2 studies · 115 people took part in strength training Little or no difference D
Very low certainty

Why this grade: Little or no difference, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; 236 people in all; a small benefit can't be ruled out; only people who finished were analysed.

Randomised trials2 studies · 236 people with results

No clear difference in breathlessness.

The evidence is very uncertain about the effect of strength training on breathlessness in long COVID. Little or no difference · very low certainty D

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • 236 people in all; a small benefit can't be ruled out
  • Only people who finished were analysed
See the 2 studies
  1. Resistance Exercise Therapy After COVID-19 Infection: A Randomized Clinical Trial. (2025)

    People in the study
    233 randomised · 193 analysed
    Dose
    rating of perceived exertion of 8 to 10 (3-5 of 10 in the first week), daily; every 2 weeks telephone or video consultation
    Outcome
    Change in MRC Dyspnea score Medical Research Council dyspnea score
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    High
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Low
  2. Effectiveness of Functional or Aerobic Exercise Combined With Breathing Techniques in Telerehabilitation for Patients With Long COVID: A Randomized Controlled Trial. (2023)

    People in the study
    54 randomised · 48 started · 43 analysed
    Dose
    8 weeks with a frequency of 3 alternate days/week for about 40 minutes per session
    Outcome
    Dyspnea (London Chest Activity of Daily Living Scale) London Chest Activity of Daily Living Scale
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Low
    Deviations from intended interventions
    High
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    High

Daily life and health overall

Daily functioning3 studies · 141 people took part in strength training Improvement C
Very low certainty

Why this grade: Improvement, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; few people (282 in all); only people who finished were analysed; the studies disagree; effect size 1.55 (large).

Randomised trials3 studies · 282 people with results

Daily functioning improved more than in the comparison group.

The evidence is very uncertain about the effect of strength training on daily functioning in long COVID. Improvement · very low certainty C

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • Few people (282 in all)
  • Only people who finished were analysed
  • The studies disagree
  • Effect size 1.55 (large)

How big was the difference?

1.55, large. The effect size compares strength training with standard care.

See the 3 studies
  1. Resistance Exercise Therapy After COVID-19 Infection: A Randomized Clinical Trial. (2025)

    Same trial, also reported in: Resistance Exercise Therapy for Long COVID: a Randomized, Controlled Trial (2025) (incremental shuttle walk test)

    People in the study
    233 randomised · 193 analysed
    Dose
    rating of perceived exertion of 8 to 10 (3-5 of 10 in the first week), daily; every 2 weeks telephone or video consultation
    Outcome
    Incremental Shuttle Walk Test distance Incremental Shuttle Walk Test
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    High
    Missing outcome data
    Some concerns
    Measurement of the outcome
    High
    Selection of the reported result
    High
  2. Effectiveness of Functional or Aerobic Exercise Combined With Breathing Techniques in Telerehabilitation for Patients With Long COVID: A Randomized Controlled Trial. (2023)

    People in the study
    54 randomised · 48 started · 43 analysed
    Dose
    8 weeks with a frequency of 3 alternate days/week for about 40 minutes per session
    Outcome
    Functional performance (30 Seconds Standing Test) 30 Seconds Standing Test
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Low
    Deviations from intended interventions
    High
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Low
  3. The Impact of Resistance Training on Equilibrium Abilities and Quality of Life in Older Adults after SARS-CoV-2 Survival. (2024)

    People in the study
    46 analysed
    Dose
    70% of 1RM; three sets of 12 repetitions, twice a week, 60 min per session for 8 weeks
    Outcome
    OSI EO overall stability index
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    High
    Deviations from intended interventions
    High
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
Quality of life3 studies · 141 people took part in strength training Improvement C
Very low certainty

Why this grade: Improvement, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; few people (282 in all); only people who finished were analysed; the studies disagree; effect size 0.68 (moderate).

Randomised trials3 studies · 282 people with results

Quality of life improved more than in the comparison group.

The evidence is very uncertain about the effect of strength training on quality of life in long COVID. Improvement · very low certainty C

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • Few people (282 in all)
  • Only people who finished were analysed
  • The studies disagree
  • Effect size 0.68 (moderate)

How big was the difference?

0.68, moderate. The effect size compares strength training with standard care.

See the 3 studies
  1. Resistance Exercise Therapy After COVID-19 Infection: A Randomized Clinical Trial. (2025)

    Same trial, also reported in: Resistance Exercise Therapy for Long COVID: a Randomized, Controlled Trial (2025) (health-related quality of life utility score (EQ-5D-5L))

    People in the study
    233 randomised · 193 analysed
    Dose
    rating of perceived exertion of 8 to 10 (3-5 of 10 in the first week), daily; every 2 weeks telephone or video consultation
    Outcome
    Change in EQ-5D-5L Health Utility score European Quality of Life 5-Dimension 5-Level Instrument
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    High
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Low
  2. Effectiveness of Functional or Aerobic Exercise Combined With Breathing Techniques in Telerehabilitation for Patients With Long COVID: A Randomized Controlled Trial. (2023)

    People in the study
    54 randomised · 48 started · 43 analysed
    Dose
    8 weeks with a frequency of 3 alternate days/week for about 40 minutes per session
    Outcome
    Quality of life (European Quality of Life Scale) European Quality of Life Scale
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Low
    Deviations from intended interventions
    High
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Low
  3. The Impact of Resistance Training on Equilibrium Abilities and Quality of Life in Older Adults after SARS-CoV-2 Survival. (2024)

    People in the study
    46 analysed
    Dose
    70% of 1RM; three sets of 12 repetitions, twice a week, 60 min per session for 8 weeks
    Outcome
    DOM2 Psychol.
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    High
    Deviations from intended interventions
    High
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns

ME/CFS

Symptoms

Depression1 study · 11 people took part in strength training Little or no difference D
Very low certainty

Why this grade: Little or no difference, very low certainty, from randomised trials: some concerns about bias (RoB 2); one trial of 11 people found no clear difference; a small benefit can't be ruled out.

The randomised trial22 randomised · 11 analysed · four weeks · 16 exercises performed with single set, moderate load and high repetitions, five days/week for four weeks

No clear difference in depression.

The evidence is very uncertain about the effect of strength training on depression in ME/CFS. Little or no difference · very low certainty D

  • Some concerns about bias (RoB 2)
  • One trial of 11 people found no clear difference; a small benefit can't be ruled out
See the 1 study
  1. Graduated exercise training and progressive resistance training in adolescents with chronic fatigue syndrome: a randomized controlled pilot study. (2010)

    People in the study
    22 randomised · 11 analysed
    Dose
    16 exercises performed with single set, moderate load and high repetitions, five days/week for four weeks
    Outcome
    Depression (BDI) Becks Depression Index
    Effect
    no clear difference
    Risk of bias
    RoB 2: Some concerns
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    Low
    Selection of the reported result
    Some concerns
Fatigue1 study · 11 people took part in strength training Little or no difference D
Very low certainty

Why this grade: Little or no difference, very low certainty, from randomised trials: some concerns about bias (RoB 2); one trial of 11 people found no clear difference; a small benefit can't be ruled out.

The randomised trial22 randomised · 11 analysed · four weeks · 16 exercises performed with single set, moderate load and high repetitions, five days/week for four weeks

No clear difference in fatigue.

The evidence is very uncertain about the effect of strength training on fatigue in ME/CFS. Little or no difference · very low certainty D

  • Some concerns about bias (RoB 2)
  • One trial of 11 people found no clear difference; a small benefit can't be ruled out
See the 1 study
  1. Graduated exercise training and progressive resistance training in adolescents with chronic fatigue syndrome: a randomized controlled pilot study. (2010)

    People in the study
    22 randomised · 11 analysed
    Dose
    16 exercises performed with single set, moderate load and high repetitions, five days/week for four weeks
    Outcome
    Fatigue Severity (FSS) Fatigue Severity Scale
    Effect
    no clear difference
    Risk of bias
    RoB 2: Some concerns
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    Low
    Selection of the reported result
    Some concerns

Daily life and health overall

Daily functioning1 study · 11 people took part in strength training Little or no difference D
Very low certainty

Why this grade: Little or no difference, very low certainty, from randomised trials: some concerns about bias (RoB 2); one trial of 11 people found no clear difference; a small benefit can't be ruled out.

The randomised trial22 randomised · 11 analysed · four weeks · 16 exercises performed with single set, moderate load and high repetitions, five days/week for four weeks

No clear difference in daily functioning.

The evidence is very uncertain about the effect of strength training on daily functioning in ME/CFS. Little or no difference · very low certainty D

  • Some concerns about bias (RoB 2)
  • One trial of 11 people found no clear difference; a small benefit can't be ruled out
See the 1 study
  1. Graduated exercise training and progressive resistance training in adolescents with chronic fatigue syndrome: a randomized controlled pilot study. (2010)

    People in the study
    22 randomised · 11 analysed
    Dose
    16 exercises performed with single set, moderate load and high repetitions, five days/week for four weeks
    Outcome
    Time to Fatigue (mins) between-group difference
    Effect
    no clear difference
    Risk of bias
    RoB 2: Some concerns
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    Low
    Selection of the reported result
    Some concerns
Quality of life1 study · 11 people took part in strength training Little or no difference D
Very low certainty

Why this grade: Little or no difference, very low certainty, from randomised trials: some concerns about bias (RoB 2); one trial of 11 people found no clear difference; a small benefit can't be ruled out.

The randomised trial22 randomised · 11 analysed · four weeks · 16 exercises performed with single set, moderate load and high repetitions, five days/week for four weeks

No clear difference in quality of life.

The evidence is very uncertain about the effect of strength training on quality of life in ME/CFS. Little or no difference · very low certainty D

  • Some concerns about bias (RoB 2)
  • One trial of 11 people found no clear difference; a small benefit can't be ruled out
See the 1 study
  1. Graduated exercise training and progressive resistance training in adolescents with chronic fatigue syndrome: a randomized controlled pilot study. (2010)

    People in the study
    22 randomised · 11 analysed
    Dose
    16 exercises performed with single set, moderate load and high repetitions, five days/week for four weeks
    Outcome
    SF-36 (PCS) short form health survey (SF-36)
    Effect
    no clear difference
    Risk of bias
    RoB 2: Some concerns
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    Low
    Selection of the reported result
    Some concerns

Side effects

Stopping because of side effects3 studies
Side effects studies reported1 kind
Side effects studies reported, and how many studies reported each
Side effectStudies that reported it
Worse symptoms or a flare1 study

All papers

  1. Immunological effects of supervised exercise in long COVID in adults: A secondary analysis of a randomized crossover trial.2026 · randomised trial · 36 analysed
    Summary

    This secondary analysis of the EXER-COVID randomized 2 × 2 crossover trial assessed immunological effects of supervised exercise in adults with long COVID at a single centre. Cytokine data were available for 36 participants (sequence AB n = 17; sequence BA n = 19), and 35 had PBMC data for exploratory lymphocyte immunophenotyping. Participants completed a 6-week supervised power resistance training program of two sessions per week on nonconsecutive days, 45–50 min per session (12 sessions), or usual care, before crossing over after a 3–5 day washout. The study measured plasma cytokines, lymphocyte immunophenotypes and innate immune populations. Of 29 lymphocyte and cytokine outcomes, five showed nominal signals before correction: CD8+CD28+CD62L−CD57−PD1+ (−2.40%‐points; p = 0.023), CD8+CD28+CD62L+CD57+KLRG1− (+5.03%‐points; p = 0.030), IL-1β (+0.47 pg/mL; p = 0.013), IL-10 (+1.14 pg/mL; p = 0.034), and MIP-1α (+0.34 pg/mL; p = 0.031). None survived BH adjustment (BH P range 0.135–0.149). No innate immune outcome reached significance after BH correction. Before each training session, participants were screened for worsening post-exertional symptoms; withdrawal counts for harms were not reported. The paper states an absence of detectable adverse immune perturbations. Limitations included a brief 3–5 day washout and modest sample size (n = 35–36).

  2. Exercise training in long COVID: the EXER-COVID trial.2025 · randomised trial · 89 analysed
    Summary

    EXER-COVID was a randomized crossover trial in non-hospitalized patients with long COVID and mild or moderate symptoms. The intervention was a 6-week personalized PRT programme of 12 supervised sessions conducted twice weekly, with a 5-day washout; the comparator phase was 6-week usual care. A total of 89 participants completed the full intervention—59 women and 30 men—and were included in the final analysis. Peak V̇O2 increased by a mean of 2.10 mL/kg/min [95% CI 1.25 to 2.94] in the ITT analysis. The paper also reports improvements in pectoral press (6.82), bilateral leg-press (36.13), knee extension (12.24), back press (7.39), depression (CES-D 10; −4.14), and psychological distress (K10; −2.28); no significant changes were observed in grip strength or body fat mass. Symptom prevalence decreased between phases for weakness (RR = 0.75 [95% CI 0.59 to 0.95]), dyspnea (RR = 0.56 [95% CI 0.39 to 0.82]), and memory loss (RR = 0.84 [95% CI 0.72 to 0.97]). The intervention was prematurely discontinued in two patients due to exercise-related events; palpitations (two events in period 1) and general pain or discomfort (two events in period 1 and one event in period 2) across three patients were reported. Two patients were withdrawn during period 1 due to SARS-CoV-2 reinfection, and four more opted out; seven participants were lost to follow-up after six weeks and an additional four at 12 weeks. The authors state that inability to blind the intervention may have introduced placebo effects and that generalizability to hospitalized patients is limited.

  3. Resistance Exercise Therapy for Long COVID: a Randomized, Controlled Trial2025 · randomised trial · 233 randomised · 193 analysed · preprint
    Summary

    This two-arm randomized controlled trial asked whether adding a personalized resistance exercise programme to usual care would improve outcomes in adults with Long COVID, defined as a hospital or community diagnosis of COVID-19 in the preceding 12 months. 233 individuals were randomized: 117 to usual care plus personalized resistance exercise for 12 weeks and 116 to usual care. The median (interquartile range) percentage adherence was 71.0 (47.8, 96.8). The primary outcome was the incremental shuttle walk test three months after randomization; secondary outcomes included health-related quality of life (EQ-5D-5L), anxiety and depression (Patient Health Questionnaire), grip strength, adverse events and the DePaul Symptom Questionnaire (Short Form). The change in shuttle walk distance at three months was 83 (118) m in the intervention group (n=94) and 47 (95) m in the control group (n=98), with an effect estimate of 36.4 (6.6, 66.2) m (p=0.017). Greater improvements were also reported for EQ-5D-5L (0.06 (0.01, 0.11); p=0.020), Patient Health Questionnaire category (0.5 (0.2, 0.8); p=0.013) and handgrip strength (2.54 (0.89, 4.19) kg; p=0.003). In 99 individuals who completed the DePaul questionnaire, post-exertional malaise occurred in 40 (83.3%) intervention and 42 (82.4%) control individuals. Serious adverse events (hospitalization) occurred in 1 intervention and Five control individuals (p=0.119). The authors report no increase in post-exercise malaise or adverse events. Limitations are not reported in the abstract.

  4. Elastic and Traditional Resistance Training Improve Muscle Strength and Reduce Symptom Severity in Individuals with Long COVID2025 · randomised trial · 13 randomised · 8 analysed
    Summary

    This quasi-experimental study enrolled 13 adults with Long COVID, recruited at two universities; five withdrew (two for travel, three unexplained), leaving eight who completed. Participants received traditional resistance training (TRAD; n=4) or elastic resistance training (ELAS; n=4), twice a week for 12 weeks. Outcomes included DSQ-COVID symptom score, handgrip strength, body composition, functional performance, blood glucose and uric acid. Repeated measures ANOVA showed no statistically significant differences for the Group*Time interaction. A significant DSQ-COVID time effect occurred (F = 13.6; p < 0.001); post-hoc differences were found only in ELAS between baseline and six weeks (p = 0.043) and pre- versus post-intervention (p = 0.045). For all participants, DSQ-COVID changed from 1215.6 ± 323.0 to 671.8 ± 398.4 (p = 0.006), HGS from 31.2 ± 8.8 to 35.3 ± 8.5 (p = 0.012), RHGS from 1.16 ± 0.4 to 1.28 ± 0.3 (p = 0.039), and SBP from 129.7 ± 12.2 to 116.6 ± 11.2 (p = 0.040). Fatigue, bone or joint pain, and memory loss did not differ pre-post (P > 0.05; effect sizes 0.76, 0.72, 0.59); Table 3 mean variations were -53.1 ± 25.7, -48.4 ± 28.7, and -50.0 (46.9 – 53.1). The abstract reported handgrip increased by 12% for all participants (P < 0.05); Table 3 reported HGS mean variation 14.3 ± 12.1. No session was terminated early due to desaturation, and no instances of desaturation or PEM were observed.

  5. Resistance Exercise Therapy After COVID-19 Infection: A Randomized Clinical Trial.2025 · randomised trial · 233 randomised · 193 analysed
    Summary

    This 2-arm, multicenter randomized clinical trial in Scotland included 233 adults with a hospital or community diagnosis of COVID-19 infection in the preceding 12 months and persisting symptoms. Participants were randomized to a personalized resistance exercise intervention for 3 months (117 individuals) or treatment as usual (116 individuals). The primary outcome was Incremental Shuttle Walk Test distance at 3 months. The mean change from baseline was 83 m in the intervention group (n=94) and 47 m in the control group (n=98), with an adjusted mean difference of 36.5 m (95% CI, 6.6-66.3 m; P=.02). Greater improvements were also reported for EQ-5D-5L utility (0.06 [95% CI, 0.01-0.11]; P=.02), PHQ-4 category (0.5 [95% CI, 0.2-0.8]; P=.01), and handgrip strength (2.6 kg [95% CI, 0.9-4.2 kg]; P=.002). The paper reports no effects on other outcomes and no statistically significant interactions on the primary outcome by prespecified subgroups. The overall withdrawal rate was 26 of 233 (11.2%). Ten hospitalizations occurred (9 for 5 individuals in the control group and 1 in the intervention group, deemed unrelated to the intervention), and no deaths occurred. Postexertional malaise was reported in 40 of 48 intervention participants and 42 of 51 control participants at 3-month follow-up. The authors state no adverse events or serious adverse events occurred in relation to the intervention. They note that outcome assessors were aware of treatment allocation and that exercise was unsupervised with self-reported adherence.

  6. The Impact of Resistance Training on Equilibrium Abilities and Quality of Life in Older Adults after SARS-CoV-2 Survival.2024 · randomised trial · 46 analysed
    Summary

    This study asked whether a resistance-training protocol could improve functional and equilibrium abilities in older adults after SARS-CoV-2 survival. Participants were post-COVID-19 seniors recruited from nursing homes, primary health care facilities, a University of the Third Age, social media of the local university, and surrounding communities. The paper reports 46 analysed participants: intervention group n = 26 and control group n = 20. The intervention was resistance training twice a week, 60 min per session for 8 weeks, at 70% of 1RM with three sets of 12 repetitions; the control group was advised to maintain usual activity. Postural stability and WHOQOL-BREF quality of life were measured pre- and post-testing. The paper reports greater improvement in OSI EO (Z = −3.12, p < 0.01, R = 0.533) and FRI 6-2 (Z = −2.06, p < 0.05, R = 0.354) in the intervention group; FRI 6-2 improved within the intervention group in men (p < 0.01) and women (p < 0.05). It reports between-group differences in DOM2 (p < 0.028), DOM3 (p < 0.0403) and Q2 (p < 0.0009), and no significant differences for MLSI EO (p = 0.0860), OSI EC (p = 0.5755), APSI EC (p = 0.7671), MLSI EC (p = 0.4752), FRI 12-8 (p = 0.5755), DOM1 (p = 0.6804), DOM4 (p = 0.4802) or Q1 (p = 0.2399). Average attendance was 93% (80–100%). Two intervention participants dropped out due to pain unrelated to participation; three control participants did not attend post-test. The paper also reports a p = 0.10870 for the APSI EO comparison, conflicting with its significant APSI EO statement.

  7. Resistance Exercise Program Is Feasible and Effective in Improving Functional Strength in Post-COVID Survivors.2024 · randomised trial · 46 randomised
    Summary

    This study asked whether a protocol-based resistance exercise program could reduce muscle weakness in older adults after COVID-19. Forty-six older adults were randomized into an intervention group and a control group. Participants were recruited from nursing homes, primary health care facilities, a University of the Third Age program, social media, posters, leaflets and videos. The intervention group received resistive training twice a week, for 60 min per session and for 8 weeks, at an exercise intensity of 70% of 1RM, with three sets of 12 repetitions on each exercise. The control group was advised to retain their activity level as usual. The study measured isometric and isokinetic strength and functional tests, including the Time Up and Go test and Chair Stand Tests. Men and women in the intervention group showed improvement in several static and dynamic strength measures. The GROUP × TESTING SESSION interaction was significant for the Chair Test (s) and Chair Test (n). Isokinetic torque interactions were not found, and there was no statistically significant improvement in Time Up and Go performance. The average attendance rate was 93% (80–100%). Two subjects were lost due to unrelated musculoskeletal pain (lower back, knee pain). The data from the 46 post-COVID seniors were analyzed, while the results section also reports the two losses. The authors state limitations included the small number of subjects, participants already functioning at a reasonably high level, inability to systematically track symptom improvement, and use of a community gym equipped with resistance exercise machines.

  8. Effectiveness of Functional or Aerobic Exercise Combined With Breathing Techniques in Telerehabilitation for Patients With Long COVID: A Randomized Controlled Trial.2023 · randomised trial · 54 randomised · 48 started · 43 analysed
    Summary

    This single-blind randomized controlled trial compared two 8-week telerehabilitation programs in adults with long COVID. Participants were recruited by contacting long COVID associations and through University of Valencia social networks. Of 54 prospective participants, 48 were eligible, agreed, and were randomly assigned; 43 completed the study (functional exercise [FE] group, n = 21; aerobic exercise [AE] group, n = 22; mean age 42.4 [SD 6.5] years). Both groups received breathing techniques via the Fisiotrack mobile phone application and either a functional exercise protocol or a progressive walking protocol, 3 alternate days/week for about 40 minutes per session. Assessments at baseline and immediately after the intervention included fatigue, dyspnea, functional performance, perceived stress, anxiety and depression, quality of life, Patient Global Impression of Change, usability, and adherence. In within-group comparisons, the FE group improved fatigue (−6.7 points; 95% CI = −11.9 to −1.3), functional capacity (2.6 repetitions; 95% CI = 0.3 to 4.9), and perceived stress (−4.9 points; 95% CI = −9.1 to 0.8); the AE group improved perceived stress (−6.2 points; 95% CI = −10.3 to −2.1). No significant intergroup differences were identified for the studied variables. Patient Global Impression of Change favored FE (P < .05; categorical χ2 = 11.48; P = .019). Usability was 86 for FE and 90 for AE; adherence was 96% for FE and 89% for AE. No participants experienced adverse effects. The authors noted the absence of a control group and that only short-term effects were evaluated and that adherence was self-reported.

  9. Graduated exercise training and progressive resistance training in adolescents with chronic fatigue syndrome: a randomized controlled pilot study.2010 · randomised trial · 22 randomised · 11 analysed
    Summary

    Twenty-two adolescents with chronic fatigue syndrome admitted to an inpatient rehabilitation programme were randomized to either graded aerobic exercise training (n=11) or progressive resistance training (n=11) for five days/week for four weeks. The aerobic training consisted of 20–40 minutes of stationary cycling and treadmill exercise; resistance training involved 16 exercises with single set, moderate load and high repetitions. Exercise tolerance (time to fatigue, metabolic equivalents), quality of life (SF-36 physical component score), muscular strength (push-ups) and endurance (sit-to-stand), fatigue severity (Fatigue Severity Scale) and depressive symptoms (Beck Depression Index) were measured before and after the four-week intervention. No significant between-group differences were found for any outcome. Within groups, time to fatigue improved significantly in the aerobic group (P2=0.008) but not in the resistance group (P2=0.1); metabolic equivalents improved significantly in the aerobic group (P2=0.03) and not significantly in the resistance group (P2=0.08). Sit-to-stand, SF-36 PCS and Beck Depression Index improved significantly in both groups. Fatigue severity improved significantly only in the aerobic group (P2=0.001) and not in the resistance group (P2>0.05). One participant in the resistance group had an injury restricting ability to complete the intervention, and withdrawals were 1 in the aerobic group and 2 in the resistance group. The authors state that both interventions were well tolerated with no adverse events recorded.

  10. Improvement of Fatigue and Body Composition in Women with Long COVID After Non-Aerobic Therapeutic Exercise Program.2025 · no comparison group · 17 in the study
    Summary

    This single-arm non-blinded exploratory case study with a pre–post format included 17 women with long COVID symptoms recruited by consecutive non-probability sampling from the Madrid LC association (AMACOP). Participants received a personalized plank-based strengthening exercise program (MORETA), with 2 60 min sessions per week on alternate days, a total of 24 sessions, for 12 weeks. There was no comparison group. Fatigue was measured with the Modified Fatigue Impact Scale and body composition with bioimpedance analysis. A total of 17 women completed the study, and no attrition was registered. General fatigue decreased after the exercise program (−14.00), with improvements in the physical (−8.65) and psychosocial (−1.70) sub-scales (p < 0.001); no significant changes were observed in the cognitive sub-scale. Total body fat changed by −1.72% (95% CI −2.57 to −0.86), trunk body fat by −2.09%, and upper and inner limb body fat showed significant differences (p < 0.05). No differences were observed for segmental and total muscle mass and visceral fat level. The percentage in the normal BMI category increased from 17.6% to 35.3%; participants with overweight or obesity comprised 70% and this value decreased by 5.9 percentage points after the program. No worsening of symptoms was reported, and no worsening of post-exertional symptoms was reported.

  11. Corona With Lyme: A Long COVID Case Study.2023 · case report · 1 in the study
    Summary

    This case report describes a previously healthy 26-year-old female medical student living in New York, NY, who developed long COVID after a presumed acute SARS-CoV-2 infection in March 2020, with a concurrent perceived early-disseminated Lyme disease infection. The three-year arc covers numerous trial-and-error treatments: a two-week regimen of doxycycline 100 mg twice a day, metformin escalation alongside diet modifications, graded compression stockings, breathing exercises, increases in caffeine and salt consumption with increased fluid intake, a horizontal cardio exercise program with rest periods, osteopathic manipulative treatment, cognitive behavioral therapy, sleep hygiene improvements, supplements (vitamin C, vitamin D, vitamin B12, B-complex, n-acetyl cysteine, turmeric extract), a two-dose Moderna mRNA COVID-19 vaccination course, and abortive headache therapies (Excedrin or Fioricet and prochlorperazine). The authors report a moderate reduction in cycle length and morning hypoglycemic symptoms with metformin, a moderate reduction in myalgias, headaches and scalp allodynia with osteopathic manipulative treatment, some relief of post-COVID headache, help with headache pain, orthostatic palpitations, fatigue and brain fog from abortive therapies plus caffeine, salt and fluid intake, moderate improvements in fatigue and brain fog in the first 24 hours after the first vaccine dose, moderate symptom alleviation from digital interventions, and small but recognizable differences in fatigue and cognition from sleep hygiene. No improvement in symptoms other than mild reduction in right shoulder pain followed the doxycycline regimen. Supplements provided no discernable benefit. The patient reports full recovery from long COVID with residual blurred vision and oligomenorrhea. Reported harms include worsening blurred vision, palpitations, heat intolerance and near-syncopal events; a moderate increase in fatigue and brain fog with a CGRP antagonist; fatigue exacerbation with traditional exercise rehabilitation; symptom re-exacerbations with compression stockings; and increased headache frequency and duration with n-acetyl cysteine. The abstract describes near-total remission.

  12. Successful outcome of musculoskeletal injury leads to a reduction in chronic fatigue: A case report.2018 · case report · 1 in the study
    Summary

    This case report describes one 19-year-old male student, referred privately, with a two-year history of left-sided shoulder girdle pain (VAS 8/10) and a diagnosis of chronic fatigue syndrome. He was treated with osteopathic manipulative treatment (OMT) over four clinical visits across a four-month period, combined with corrective exercise and orthotics. There was no comparison group. The authors report that over the course of four treatments pain level reduced from 8/10 to 0/10, strength testing increased from 4/5 to 5/5, and GHJ testing improved (5/5). By the fourth visit the patient reported participation in a cricket match and had experienced no reaction in shoulder symptoms or increase in CFS levels. The patient also reported that, in their opinion, due to a reduction in pain, their CFS might have improved. The authors note limitations including a lack of quantitative and qualitative outcome measures, the retrospective collection of information, and the possibility that the patient might have recovered naturally without osteopathic intervention. They also state that fatigue was never actually measured and that the present study cannot state that specific shoulder exercises were any better compared to general gym sessions for the management of CFS.

  13. Adolescents with severe chronic fatigue syndrome can make a full recovery.2011 · case report
    Summary

    This case report describes one 11-year-old boy with chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) who was virtually housebound and used a wheelchair. He was referred to a specialist unit after an 18-month illness. He received a home-based assessment and treatment package over 18 months: 25 sessions lasting between 1½ and 2 h, encouraging a consistent pattern of activity and rest, then gradually increasing activity and establishing a sleep routine. A community physiotherapist encouraged stretching and strengthening exercises, and he did aqua-aerobics weekly; a home tutor helped with schoolwork. There was no comparison group. Self-report measures of fatigue and social adjustment were given before treatment, at discharge, and at 6, 12 and 36 months post treatment; school attendance was also shown over time. At discharge, after 23 sessions over 19 months, he was back at school full-time but not participating in sports. At 3-month follow-up, his parents felt he was ‘back to normal’, and gains were maintained at 6 and 12 months. At 36 months post discharge, treatment questionnaire scores showed gains maintained. By 54 months after treatment ended, his mother reported good A level results and a sports scholarship. Harms and withdrawals were not reported. The authors state no research to date has focused on the management of severely affected adolescents with CFS/ME.

  14. Effectiveness of physical, psychological, and alternative interventions for post-COVID-19 condition: a systematic review.2026 · systematic review
    Summary

    This systematic review asked whether supervised physical, psychological and alternative non-pharmacological treatments help adults with post-COVID-19 condition. It included 27 randomized trials with 1,998 participants; trials were supervised and face-to-face and compared interventions with usual care, placebo/sham or active comparators. Interventions included cardiopulmonary rehabilitation, multimodal and unimodal exercise, CBT and lifestyle programmes, neuromodulation, oxygen therapies, acupuncture and balneotherapy. Intervention durations varied. The review reported that cardiopulmonary rehabilitation and multimodal exercise consistently improved cardiorespiratory fitness and walking capacity; CBT and lifestyle adjustments significantly reduced fatigue and subjective concentration complaints. Examples recorded: in 114 participants, CBT lowered CIS-fatigue by a between-group mean difference of −8.8 points (95% CI −11.9 to −5.8); in 70 participants, active HD-tDCS plus rehabilitation lowered MFIS total fatigue by a between-group difference of −14.03 points (95% CI −20.28 to −7.78). Findings for neuromodulation, complementary and oxygen therapies were heterogeneous, often showing no benefit over placebo. For example, HBOT did not produce significantly greater improvements than sham on any primary or secondary outcome. Side effects and withdrawals were not reported in the recorded data. The authors state that the evidence does not support definitive conclusions about the effectiveness of any intervention category.

  15. Dropouts in Exercise Rehabilitation Program in Patients With Long COVID: A Systematic Review.2025 · systematic review
    Summary

    Objective: to describe dropout rates, reasons, and factors associated with dropout during rehabilitation programs for patients with long COVID. The review included 23 studies with 1,523 patients with long COVID (mean age 53.0 ± 6.4 yrs; 51% female). Eligible programs were exercise interventions lasting at least 4 weeks for patients aged 18 or older of both sexes. The review did not compare one exercise regimen against another; it pooled dropout data and compared dropout ratios across study variables. The main outcome was dropout rate, recorded as absolute numbers and frequency, and the secondary outcome was reasons for dropout. Of 1,523 patients enrolled, 216 withdrew, constituting 14.2% of the total sample. Grouped dropout reasons were not reported (31.0%), health issues (23.1%), did not complete assessments (19.4%), loss of interest (15.7%), lack of adherence (6.9%), and adherence to other interventions (3.7%). Individual included studies listed side effects (n = 5), symptoms exacerbation (n = 1), musculoskeletal issue (n = 1), other acute health conditions (n = 2), and hospitalization (n = 1) as dropout reasons. The review reports no significant associations between dropout rate and remaining variables. The authors state that dropout rates were 14% and that health-related issues and incomplete assessments were the most common reasons.

  16. Effects of therapeutic interventions on long COVID: a meta-analysis of randomized controlled trials.2025 · systematic review
    Summary

    This meta-analysis pooled 51 RCTs with 4026 participants with Long COVID, searching PubMed, Cochrane Library, Embase, Web of Science, SPORTDiscus (EBSCO), CINAHL (EBSCO), and Rehabilitation & Sports medicine source (EBSCO) to July 20, 2025. Trials compared exercise training, respiratory muscle training, telerehabilitation, tDCS, olfactory training, steroid sprays, or PEA-LUT with no intervention, standard primary care, or placebo; follow-up ranged from 14 to 180 days. Outcomes included cardiopulmonary function, exercise capacity, fatigue, dyspnea, and olfactory recovery. Exercise training showed significant better 6MWT (MD 83.20; 95% CI 52.04–114.37) and 30sSTS (MD 3.05; 95% CI 1.96–4.13), but no significant difference for HADS-depression, HADS-anxiety, SF-12-PCS, FVC (% predicted), FEV1, VE/VO2, VE, RER, or FEV1/FVC. Respiratory muscle training showed significant better 6MWT (MD 89.54; 95% CI 9.86–169.23) and MIP (cm H2O) (MD 19.69; 95% CI 10.14–29.24), with no significant difference for FVC, FEV1, MFIS, HADS, or MEP. Telerehabilitation showed significant better 6MWT (MD 34.14; 95% CI 2.54–65.74), 30sSTS (MD 1.41; 95% CI 0.67–2.15), and FSS (MD −1.59; 95% CI −2.64 to −0.53). tDCS showed significant lower MFIS-physical (MD −2.29; 95% CI −4.36 to −0.22). Olfactory training and steroid sprays showed no significant differences; PEA-LUT showed significant higher TDI Score (MD 4.66; 95% CI 2.16–7.15). No side-effect or withdrawal counts were reported; the authors noted exercise may pose a risk of symptom exacerbation in post-exertional malaise. They reported high risk of bias in 33 studies and high heterogeneity.

  17. Effect of nonpharmacologic therapies on depressive symptoms in patients with chronic fatigue syndrome: a network meta-analysis.2025 · systematic review
    Summary

    This network meta-analysis examined nonpharmacologic therapies for depressive symptoms in patients with chronic fatigue syndrome (CFS). The authors searched PubMed, Cochrane Library, Web of Science, Embase, CNKI, Wanfang, CBM, VIP, and Sinomed for randomized controlled trials until March 26, 2025, and included 47 RCTs involving 4,028 participants. The review compared nonpharmacologic interventions with control conditions and measured depression or depressive symptoms with scales. Compared with control, the review reports significant differences for acupuncture (SMD = -1.91, 95% CI: -2.9 to -0.94), moxibustion (SMD = -2.91, 95% CI: -4.61 to -1.22), Tuina (SMD = -2, 95% CI: -3.64 to -0.38), diet therapy (SMD = -5.64, 95% CI: -8.98 to -2.29), electrical stimulation (SMD = 1.9, 95% CI: 0.03 to 3.78), Ap + Mox (SMD = 2.53, 95% CI: 1.17 to 3.91), and Ap + Mox + Ae (SMD = 3.16, 95% CI: 0.39 to 5.98). The review states that relaxation therapy, AER, RT, and Qigong did not markedly improve depressive symptoms, and psychotherapy did not show significant effects. Harms were not reported as counts; the review includes a statement that graded exercise therapy may exacerbate symptoms in certain CFS patients, a statement about exercise therapy, the patient’s energy limit, characteristic post-exertional malaise (PEM), and efficacy, and a statement that Tuina has no adverse reactions. The authors state heterogeneity, inconsistent depression scales, and medium risk of bias in most included studies, with some interventions from few small studies, so results should be viewed with caution.

  18. Clinical efficacy of exercise in the treatment of post-COVID-19 syndrome: a systematic review and network meta-analysis.2025 · systematic review
    Summary

    This systematic review and network meta-analysis asked whether exercise therapy helps post-COVID-19 syndrome (PCS), described as persistent or new symptoms beyond the acute phase of SARS-CoV-2 infection. The authors searched PubMed, Embase, Web of Science, and Ovid through 25 March 2025 and included 33 randomized controlled trials with 2,895 participants. Exercise interventions were grouped as aerobic exercise (AE), respiratory muscle training (RMT), resistance training (RT), combinations, or no exercise therapy. Outcomes included FEV1/FVC, peak VO2, six-minute walk test (6MWT), mMRC dyspnea score, and Mental Health/Mental Component Summary scores. For FEV1/FVC, AE + RMT ranked highest (97.62%), followed by AE (76.33%) and RMT (40.62%); the text states AE + RMT was better than the other treatments except AE, while AE was better than no exercise therapy. For peak VO2, the experimental group had a statistically significant reduction compared with control (Z = 3.02, P = 0.003; I2 = 0%). The 6MWT distance showed a statistically significant advantage for the experimental group (Z = 6.13, P < 0.00001; I2 = 83%), and AE + RMT + RT was better than no exercise intervention (Z = 14.26, P < 0.00001; I2 = 0%). mMRC was better in the experimental group (Z = 2.88, P = 0.004; I2 = 95%). MH (Z = 2.63, P = 0.008; I2 = 0%) and MCS (Z = 4.09, P < 0.0001; I2 = 10%) were significantly better in the experimental group than in the control group. No difference, worsening, stopping, or side-effect counts were reported in the text provided.

  19. Comparative efficacy of various exercise therapies for chronic fatigue syndrome: A systematic review and network meta-analysis.2025 · systematic review
    Summary

    This systematic review and network meta-analysis asked whether exercise therapies help chronic fatigue syndrome (CFS). The review included 25 randomized controlled trials; 20 trials (n = 2,831) were eligible for network meta-analysis, and 3,602 patients with CFS were included overall. Exercise modalities were GET, Qigong, Yoga, strength/resistance training, and running, compared with waitlist, specialist medical care, or relaxation/flexibility. Outcomes were fatigue, depression, anxiety, physical function, and sleep quality. For fatigue at the end of treatment, GET compared with waitlist had MD −6.93 (95% CI −10.85 to −3.01; moderate certainty); Qigong MD −5.02 (95% CI −9.79 to −0.25; low certainty); running MD −9.66 (95% CI −18.20 to −1.12; very low certainty); strength/resistance training MD −5.79 (95% CI −14.17 to 2.58; very low certainty); Yoga MD −3.89 (95% CI −12.89 to 5.11; very low certainty). For depression, GET MD −5.27 (95% CI −7.38 to −3.16; low certainty). For anxiety, GET MD −2.88 (95% CI −5.10 to −0.66; low certainty). For physical function, GET MD 6.41 (95% CI 4.87 to 7.96; moderate certainty), and Qigong MD 2.30 (95% CI −0.77 to 5.37; low certainty). For sleep, GET MD −2.32 (95% CI −4.35 to −0.29) and Qigong MD −1.30 (95% CI −2.44 to −0.16), both low certainty. The authors state that physical function and sleep improvements remained below clinically meaningful thresholds. The text mentions symptom exacerbation in 'some patients' but gives no count for this review.

  20. Post-Acute COVID-19 Syndrome (PACS) and Exercise Interventions: A Systematic Review of Randomized Controlled Trials.2025 · systematic review
    Summary

    This systematic review asked whether exercise interventions affect health-related quality of life and functional fitness in adults with Post-Acute COVID-19 Syndrome. It searched databases and clinical registers up to July 2025 and included 20 randomized controlled trials. Exercise programmes varied: aerobic training, resistance or concurrent training, breathing exercises, strength-based exercises, pilates, yoga disciplines and telerehabilitation; one study used continuous aerobic training at 50% of workload. Durations included a 2-week protocol and an 8-week protocol. Comparators included usual care, waitlist, no intervention, general guidance, another exercise setting or another exercise delivery. Outcomes were HRQoL and functional fitness. Some trials reported significant HRQoL improvements (Refs. [30,39,46]) and positive SF-12 physical and mental components (Refs. [27,29,35]). Ref. [32] found no significant quality-of-life change between supervision by a general or specialized physiotherapist, though the SF-12 physical component changed. Ref. [33] found virtual reality was not superior to traditional methods. Ref. [31]’s 2-week breathing- and strength-based protocol and Ref. [41]’s 8-week breathing, pilates and yoga protocol were described for respiratory function. Overall dropout rates were below 37%; treatment-attributed harms were not reported. The authors state limits include heterogeneity of protocols and non-comparable frequency, duration, and modality.

  21. Physical Training Protocols for Improving Dyspnea and Fatigue in Long COVID: A Systematic Review with Meta-Analysis.2025 · systematic review
    Summary

    This systematic review with meta-analysis asked which physical training protocols are used by people with long COVID to alleviate dyspnea and fatigue. The search was conducted in October 2023; 25 articles were included. The review included primary experimental studies of individuals living with long COVID; its comparison was “not applicable.” Training protocols were mostly combinations of methods, most commonly respiratory muscle training with strength and aerobic training. Other protocols included concurrent training, inspiratory muscle training (IMT), concurrent training with IMT, a self-directed program following WHO recommendations, and aerobic training alone. The text does not report a single duration for these protocols. Dyspnea and fatigue were assessed with questionnaires. Of the 17 studies that assessed dyspnea, 11 showed significant improvement after physical exercise rehabilitation; of the 20 that assessed fatigue, 10 showed significant improvement after physical training. A meta-analysis of two studies found no significant effect on reducing fatigue compared with the control group (intervention participants: 37; control: 38; 95% CI: 15.42 to 8.77; I2: 89%). A study showed periods of worsening fatigue and dyspnea as a fluctuating pattern, and in some sessions an increase in fatigue and dyspnea intensity after excessive effort. Stopping and side effects were not reported. The authors state most studies had a moderate to high risk of bias and heterogeneity limited a more comprehensive meta-analysis.

  22. Respiratory Muscle Strength Training in Patients Post-COVID-19: A Systematic Review.2024 · systematic review
    Summary

    This systematic review evaluated respiratory muscle strength training for individuals with post-COVID-19 dyspnea. The authors searched CINAHL, Web of Science, PubMed, EMBASE, Google Scholar, and Scopus for articles from 2020-2023; eleven articles met the inclusion criteria. The abstract does not report how many participants were included, the treatment duration, the comparison conditions, or the settings of the included studies. It states that pulmonary measures improved and that dyspnea, physical capacity and quality of life measures achieved statistical significance. The authors concluded: “Outcomes improved following respiratory muscle strength training as a standalone intervention, or with aerobic and peripheral muscle strength training.” Because this is a systematic review, that statement is the authors' conclusion across the included articles, not a finding of a new study. The abstract does not report side effects, withdrawals, or limitations. No individual study results, participant numbers, or harms are given in the abstract. The abstract also gives no details about the included study designs or participant characteristics.

  23. Rehabilitation and COVID-19: systematic review by Cochrane Rehabilitation.2023 · systematic review
    Summary

    This systematic review asked what evidence exists on interventions for rehabilitation for COVID-19-related limitations of functioning in adults with COVID-19 or post COVID-19 condition (PCC). It included 53 RCTs with 3882 randomized participants; included adults were hospitalized or managed at home, and the review covered non-severe, severe, critical COVID-19 and PCC. Interventions were compared with usual care, sham/placebo, no treatment, or another active intervention; duration was not reported. Outcomes covered body functions, activities and participation, quality of life, and adverse events. The review synthesized evidence narratively. It reports that the effect of breathing and strengthening exercise programs on dyspnea and physical exercise capacity compared to no treatment in non-severe COVID-19 patients is uncertain. Multicomponent telerehabilitation may slightly increase physical exercise capacity compared to educational intervention in adults with PCC, but uncertainty remains about its effect on lung function and physical exercise capacity compared to no treatment; it reported no evidence of an effect on FVC and FEV1/FVC% for multicomponent telerehabilitation compared to no treatment in PCC. The effect of inspiratory muscle training on maximal inspiratory pressure compared to no treatment in adults with PCC is uncertain. For harms, four grouped studies and fourteen studies reported no adverse events; five and three mild adverse events (transient skin redness) occurred in active HD-tDCS and sham groups, respectively; one person in the sham group presented symptom exacerbation; olfactory training had two (0.8%) headache reports and one (0.4%) worsening parosmia report. The authors state they cannot provide robust suggestions for practice.

  24. What treatments work for anxiety and depression in children and adolescents with chronic fatigue syndrome? An updated systematic review.2022 · systematic review
    Summary

    This systematic review updated searches from 2015 to 2020 in Cochrane Library, Medline, Embase and PsycINFO for studies of children and adolescents with CFS/ME and validated measures of depression and/or anxiety. Combined with previous reviews, 16 studies and 965 participants were included; follow-up ranged from immediately post-treatment to 21 years. Treatments included CBT, the Lightning Process, valacyclovir, pacing, gammaglobulin, placebo, and inpatient or specialist care programmes. An RCT compared Lightning Process plus specialist medical care with specialist medical care alone; the review reports adjusted mean differences in depression and anxiety scores at 6 and 12 months, for example depression −1.5 (−3.5 to 0.5, 0.1) at 6 months and −1.8 (−3.4 to −0.1, 0.04) at 12 months. An observational cohort of routine specialist care measured depression and anxiety at baseline but not post-treatment. CBT-type interventions had most evidence for improving comorbid anxiety and/or depressive symptoms, but delivery and modality varied. A trial reported a deterioration in school attendance in the pacing arm. The review reports insufficient evidence to draw conclusions, and no study specifically targeted depression or anxiety. The authors state the evidence is poor and insufficient for meta-analysis.

  25. Treatment for paediatric chronic fatigue syndrome or myalgic encephalomyelitis (CFS/ME) and comorbid depression: a systematic review.2016 · systematic review
    Summary

    This systematic review asked which treatments for depression are effective in children and young people with CFS/ME, and whether comorbid depression affects outcome. MEDLINE, EMBASE, PsycInfo and the Cochrane library were searched in February 2015; 9 studies met the inclusion criteria. No study specifically tested a treatment for paediatric CFS/ME with depression, and no study stratified outcome by depression severity. Included studies examined CBT-based rehabilitation (up to 15 hourly sessions; n=23), telephone CBT guided self-help (6 fortnightly 30-minute sessions; n=63, 52 at follow-up), 4-week multicomponent inpatient programmes (n=39, 19 at follow-up; n=16; RCT n=22 comparing aerobic and resistance training), and valacyclovir (n=15, 14 at follow-up; treatment 3 to 60 months, mean 27.9 months). Depression and fatigue were measured. There was no overall comparison group; the included RCT compared aerobic with resistance training. Chalder et al reported depression significantly improved; Denborough et al reported mean BDI was 21 pretreatment and 15 post-treatment and improvement maintained at 6-month follow-up; Gordon and Lubitz reported significant improvement in BDI and Fatigue Severity scores; both RCT arms improved in BDI; Lloyd et al reported improvements in depression at 6 months; Henderson et al reported depression symptoms decreased in depressed and non-depressed patients and all patients reported at least 80% self-rated improvement. Kawatani et al found no significant improvement in fatigue at 6-month follow-up; mood was not reassessed. Reported concerns included that SSRIs can increase suicidality and that exercise could exacerbate symptoms in patients with CFS/ME; Denborough et al reported internalising problems escalated above preadmission levels.

  26. Interventions in pediatric chronic fatigue syndrome/myalgic encephalomyelitis: a systematic review.2013 · systematic review
    Summary

    This systematic review searched CINAHL, PsycINFO and Medline to May 2012, with a limited update in October 2012, for studies of interventions in children and adolescents with CFS/ME. It included 24 articles based on 21 studies, with variable designs and quality. In Wright (2005), 13 participants were randomized to a structured tailored incremental rehabilitation program or pacing; the review reports improvements in activity and school attendance with the program immediately after treatment compared with pacing. Viner (2004) reported 43% of the treatment group had complete resolution of CFS/ME compared with 4.5% with supportive care. Lim (2002) reported that before an inpatient program 94% attended school less than half-time, and 78% attended full-time or with occasional absences only at follow-up. Szyndler (2003) reported problem improvement or resolution in 31% by clinician rating and 86% by family rating. Van Geelen (2010) reported 52% nearly complete improvement and 48% no improvement. For harms, Rowe (1997) reported adverse effects common, and Nijhof (2012) reported no serious adverse events. The authors state that methodological inadequacies and inconsistent approaches limit interpretation.

  27. Cognitive behavioral therapy and graded exercise for chronic fatigue syndrome: A meta‐analysis.2011 · systematic review
    Summary

    This meta-analysis asked whether cognitive behavioral therapy (CBT) and graded exercise therapy (GET) show positive effect sizes in chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis (ME). Twenty studies were included: five GET trials (N = 170) and 16 CBT trials (N = 1,457); one trial contributed an effect size to both groups, leading to a total of 21 effect sizes. Trials were identified through database and reference searching in April 2011. CBT and GET were compared with control conditions and with each other. CBT treatment contact across trials ranged from 6 to 16 hours. Outcomes were post-treatment fatigue, anxiety, depression and functional impairment. The pooled overall effect size was g = 0.26 (CI = 0.08, 0.43) for GET and g = 0.33 (CI = 0.23, 0.43) for CBT. Fatigue effect sizes were g = 0.41 for GET and g = 0.36 for CBT; functional impairment g = 0.39 for GET and g = 0.36 for CBT; depression g = 0.15 for GET and g = 0.32 for CBT; anxiety g = 0.01 for GET and g = 0.15 for CBT. There were no significant differences between the two treatment types on overall outcome or the four outcome categories. Across studies, a median of 12% of GET participants (range = 10–18) and 17% of CBT participants (range = 0–46) dropped out of treatment or did not complete post-treatment assessment measures. Worsening and side effects were not reported.

  28. Impact of nutrition on long COVID.2026 · review
    Summary

    This narrative review examined nutritional and exercise interventions for long COVID; it did not report its own cohort. It describes a single-site RCT with n = 151 participants; n = 98 received VitK2/D3 and n = 53 received standard of care, and participants who received Vit K2/D3 showed a 7.1% reduction in long COVID symptoms compared to control group. A randomized, double-blind, placebo-controlled trial with n = 80 patients (n = 40 post COVID patients; n = 40 placebo) gave 60 000 IU of Vitamin D weekly for 8 weeks; the vitamin D group showed significant improvements in CFQ, DASS-anxiety and ACE, but no significant changes were found PQSI, DASS depression, TMT, IL-6 or CRP levels; Table 2 entry 11 reported this vitamin D supplementation with very low side effects. A multicentre trial with n = 144 patients (n = 71 vitamin D3 group; n = 71 placebo group) gave a single oral dose of 200 000 IU Vitamin D3 and found no significant differences between Vit D3 and placebo group for listed symptoms and quality of life upto 1 year of follow up. Probiotic mixture VSL#3® reduced fatigue and significantly improved physical functioning and gasterointestinal symptoms. Stopping or worsening was not reported. The review states limitations in trial design.

  29. Candidate treatments for long COVID: a narrative review of expert and patient-driven priorities.2026 · review
    Summary

    This narrative review used pragmatic methods and searches up to January 2025 to map candidate treatments for long COVID that clinicians and people with lived experience prioritised. No participant total for the review itself was reported. Evidence was summarised across intervention groups. A moderate-quality RCT of 155 participants found no significant improvement with Paxlovid. In a non-randomised controlled trial of fexofenadine plus famotidine, 14 patients were in the treatment group and 13 in the control group; 29% of treated patients had complete resolution of long COVID symptoms, and all treated patients showed significant improvement in fatigue, brain fog, abdominal disorders, and increased heart rate compared with controls. A single case report found eight out of 12 reported improved cognitive abilities with guanfacine plus N-acetylcysteine; four patients discontinued therapy, two for unspecified reasons and two due to hypotension and/or dizziness. A pilot RCT of 13 participants found active taVNS (n = 8) improved fatigue, mood, and cognitive symptoms compared with sham (n = 5), with no serious adverse events observed. A small RCT found no significant differences with 700 mg leronlimab. Two RCTs did not report any benefit from CoQ10. A case study of 4 participants reported symptom improvements up to 6 months after nicotine patches 7.5 mg per day for 7 days. Five RCTs reported multicomponent interventions improved quality of life and dyspnoea, with no strong evidence for other symptoms; 16 RCTs examined exercise training.

  30. Exercise and Cardiovascular Risk Modulation in Post-COVID Syndrome.2026 · review
    Summary

    This narrative review asked how exercise might modify cardiovascular risk in post-COVID syndrome (PASC). It searched PubMed/MEDLINE, Embase, Scopus and Web of Science for publications from January 2020 through March 2026; no overall number of included studies or participants was reported. The review summarized exercise studies in people with post-COVID syndrome or COVID-19 survivors. Interventions included aerobic, resistance, combined, respiratory, supervised endurance and concurrent training, compared with non-exercise, usual care, or unsupervised home-based groups. Durations included 8 weeks, a 12-week supervised program. Du et al. included 33 randomized controlled trials and 2,895 participants; Tartibian et al. included 296 COVID-19 survivors aged 20–93 years; Ferrari et al. analyzed 1,171 participants from eighteen RCTs; one prospective trial had 24 patients. Reported findings included improved functional capacity, dyspnea and quality of life; increased VO₂peak and reduced fatigue; improved functional capacity and muscle strength, with low to very low certainty; and reductions in CRP and pro-inflammatory chemokines. Effects on quality of life and cardiopulmonary efficiency outcomes were less consistent. The review stated the evidence does not yet demonstrate that exercise reverses accelerated vascular aging or reduces major adverse cardiovascular events. It reported no side-effect counts and stated post-exertional symptom exacerbation should be monitored for 24–48 h post-exercise. No counts of people who worsened or stopped were reported.

  31. Physiotherapy interventions in post- and long-COVID-19: a scoping review of the literature up to February 2023.2025 · review
    Summary

    This scoping review asked what physiotherapy interventions and treatment parameters have been published for post- and long-COVID-19. The authors searched PubMed, EBSCO, Scopus, Web of Science, Embase, PEDRO, Cochrane and WISO in March 2023 and included 6 studies; they state no published study focusing on long-COVID-19 was identified. The included studies covered respiratory therapy, aerobic training, strength training, and in a study ‘hands-on’ physiotherapy. Comparisons varied: some randomised trials compared training or breathing interventions between groups, while case reports described before-and-after courses. Reports included 60 patients (31 female, 29 male), 52 men, 65 men, 32 patients (20 female, 12 male), and case reports of a 37-year-old woman and a 60-year-old woman. Measured outcomes included fatigue, walking distance, dyspnoea, quality of life, muscle strength, lung function and adverse events. Reported changes included fatigue reduction, for example Nagy study group from 43.36 to 28.68 and control group from 42.47 to 39.77, and walking distance increases, for example Rutkowski VR group from 502 to 558 m and control group from 512 to 552 m. Muscle mass and lung function were reported as unchanged; one case report reported decreased quality of life. The authors state treatment descriptions were often inadequate and the data were summarised descriptively, limiting conclusions about effectiveness.

  32. Rehabilitation Strategies for Post-COVID-19 Syndrome: The Role of Physical Therapy in Addressing Long-Term Pulmonary, Musculoskeletal, and Neurological Complications2022 · review
    Summary

    This review examined evidence-based rehabilitation strategies for post-COVID-19 syndrome (long COVID). It does not report the number of patients, where they were treated, or a comparison group; the review itself had no comparison group. The review describes physical therapy approaches including pulmonary rehabilitation, resistance training, flexibility exercises, functional mobility training, balance and cognitive rehabilitation, tele-rehabilitation, and multidisciplinary coordination. Cited programmes included a 12-week aerobic training program and 12-week musculoskeletal rehabilitation programs. Outcomes described included lung function, respiratory discomfort, six-minute walk distance, peak VO2, muscle strength, functional independence, stiffness, pain, risk of falling, postural control, functional mobility scores, and cognitive test scores. The review reports that cited studies found diaphragmatic breathing improved lung function and reduced respiratory discomfort; a 12-week aerobic training program increased six-minute walk distance and peak VO2; resistance training improved muscle strength and functional independence; dynamic stretching decreased stiffness and pain; functional mobility training helped independence and reduced risk of falling; balance exercises increased postural control and decreased risk of falls; a systematic review found 20-30% improved respiratory efficiency; 12-week musculoskeletal rehabilitation programs improved functional mobility scores by 40%; neurological rehabilitation had a 50% reduction in risk of falling and a 30% improvement in cognitive test scores. No side effects or withdrawals were reported for the review. The authors state rehabilitation services are still limited, especially in rural and deprived areas, and that no adequate standardized rehabilitation protocols currently exist for clinicians.

  33. Management of chronic fatigue syndrome/myalgic encephalomyelitis in a pediatric population: A scoping review.2020 · review
    Summary

    This scoping review examined peer-reviewed research on managing chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) in a pediatric population aged under 18 years. The authors searched electronic databases and included 29 peer-reviewed research articles; no new participants were enrolled. The review grouped findings under nutrition/dietary components, exercise therapy, psychosocial factors, and multifaceted treatment. Included studies evaluated CBT with biofeedback, the Lightning Process plus standard medical care, aerobic graded exercise versus progressive resistance training, graded activity/exercise with family sessions, dietary changes, pacing versus STAIRway to Health, and other programs. Outcomes included fatigue severity, school attendance, physical function, anxiety and depression, quality of life, and global health. The review reports that included studies found lower fatigue severity and higher school attendance with CBT plus biofeedback, improvement with Lightning Process plus standard medical care, and no significant difference between aerobic graded exercise and progressive resistance training for physical capacity and QOL, while fatigue and depressive symptoms improved only in the aerobic group. No harms, side effects, worsening or withdrawals were reported in the recorded data. The authors state a lack of research in younger children and insufficient evidence for dietary modifications or supplements in prepubescent children.

A little hope, every Sunday

New recovery stories and data-driven research on ME/CFS and long COVID. Ideas worth considering, and the evidence behind them.

Free · Unsubscribe anytime